197 related articles for article (PubMed ID: 32165331)
1. Enhanced protective immune response of foot-and-mouth disease vaccine through DNA-loaded virus-like particles.
Lu Y; Dong H; Li J; Li L; Wang M; Liu H; Teng Z; Zhang Y; Jin Y; Guo H; Yang Y; Wen X; Sun S
Microb Pathog; 2020 Jun; 143():104130. PubMed ID: 32165331
[TBL] [Abstract][Full Text] [Related]
2. Novel immunogenic baculovirus expressed virus-like particles of foot-and-mouth disease (FMD) virus protect guinea pigs against challenge.
Bhat SA; Saravanan P; Hosamani M; Basagoudanavar SH; Sreenivasa BP; Tamilselvan RP; Venkataramanan R
Res Vet Sci; 2013 Dec; 95(3):1217-23. PubMed ID: 23969204
[TBL] [Abstract][Full Text] [Related]
3. Comparative efficacy of virus like particle (VLP) vaccine of foot-and-mouth-disease virus (FMDV) type O adjuvanted with poly I:C or CpG in guinea pigs.
Terhuja M; Saravanan P; Tamilselvan RP
Biologicals; 2015 Nov; 43(6):437-43. PubMed ID: 26493006
[TBL] [Abstract][Full Text] [Related]
4. Chimeric virus-like particles elicit protective immunity against serotype O foot-and-mouth disease virus in guinea pigs.
Liu X; Fang Y; Zhou P; Lu Y; Zhang Q; Xiao S; Dong Z; Pan L; Lv J; Zhang Z; Zhang Y; Wang Y
Appl Microbiol Biotechnol; 2017 Jun; 101(12):4905-4914. PubMed ID: 28365796
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of DNA vaccine (P12A3C-pcDNA) efficacy against foot-and-mouth disease by coadministration of interleukin-18-expressing (IL18 pcDNA) plasmid in guinea-pigs.
Siva Reddy K; Muralidhar Rao D; Badrinaryana N; Suryanaryana VV; Reddy GR
FEMS Immunol Med Microbiol; 2010 Dec; 60(3):261-9. PubMed ID: 21039923
[TBL] [Abstract][Full Text] [Related]
6. Protection of a novel epitope-RNA VLP double-effective VLP vaccine for foot-and-mouth disease.
Dong YM; Cai JC; Chen HT; Chen L
Antiviral Res; 2016 Oct; 134():108-116. PubMed ID: 27565990
[TBL] [Abstract][Full Text] [Related]
7. Foot-and-mouth disease virus-like particles produced by a SUMO fusion protein system in Escherichia coli induce potent protective immune responses in guinea pigs, swine and cattle.
Guo HC; Sun SQ; Jin Y; Yang SL; Wei YQ; Sun DH; Yin SH; Ma JW; Liu ZX; Guo JH; Luo JX; Yin H; Liu XT; Liu DX
Vet Res; 2013 Jul; 44(1):48. PubMed ID: 23826638
[TBL] [Abstract][Full Text] [Related]
8. Novel expression of immunogenic foot-and-mouth disease virus-like particles in Nicotiana benthamiana.
Veerapen VP; van Zyl AR; Wigdorovitz A; Rybicki EP; Meyers AE
Virus Res; 2018 Jan; 244():213-217. PubMed ID: 29196195
[TBL] [Abstract][Full Text] [Related]
9. Golden-star nanoparticles as adjuvant effectively promotes immune response to foot-and-mouth disease virus-like particles vaccine.
Teng Z; Sun S; Chen H; Huang J; Du P; Dong H; Xu X; Mu S; Zhang Z; Guo H
Vaccine; 2018 Oct; 36(45):6752-6760. PubMed ID: 30268733
[TBL] [Abstract][Full Text] [Related]
10. Novel chimeric foot-and-mouth disease virus-like particles harboring serotype O VP1 protect guinea pigs against challenge.
Li H; Li Z; Xie Y; Qin X; Qi X; Sun P; Bai X; Ma Y; Zhang Z
Vet Microbiol; 2016 Feb; 183():92-6. PubMed ID: 26790940
[TBL] [Abstract][Full Text] [Related]
11. Hollow mesoporous silica nanoparticles as delivery vehicle of foot-and-mouth disease virus-like particles induce persistent immune responses in guinea pigs.
Bai M; Dong H; Su X; Jin Y; Sun S; Zhang Y; Yang Y; Guo H
J Med Virol; 2019 Jun; 91(6):941-948. PubMed ID: 30701562
[TBL] [Abstract][Full Text] [Related]
12. Comparison of immune responses to different foot-and-mouth disease genetically engineered vaccines in guinea pigs.
Yao Q; Qian P; Huang Q; Cao Y; Chen H
J Virol Methods; 2008 Jan; 147(1):143-50. PubMed ID: 17963851
[TBL] [Abstract][Full Text] [Related]
13. Promising MS2 mediated virus-like particle vaccine against foot-and-mouth disease.
Dong YM; Zhang GG; Huang XJ; Chen L; Chen HT
Antiviral Res; 2015 May; 117():39-43. PubMed ID: 25676866
[TBL] [Abstract][Full Text] [Related]
14. Mutation in the VP2 gene of P1-2A capsid protein increases the thermostability of virus-like particles of foot-and-mouth disease virus serotype O.
Ganji VK; Biswal JK; Lalzampuia H; Basagoudanavar SH; Saravanan P; Tamil Selvan RP; Umapathi V; Reddy GR; Sanyal A; Dechamma HJ
Appl Microbiol Biotechnol; 2018 Oct; 102(20):8883-8893. PubMed ID: 30136205
[TBL] [Abstract][Full Text] [Related]
15. The effect of bovine IFN-alpha on the immune response in guinea pigs vaccinated with DNA vaccine of foot-and-mouth disease virus.
Guo HC; Liu ZX; Sun SQ; Leng QW; Li D; Liu XT; Xie QG
Acta Biochim Biophys Sin (Shanghai); 2004 Oct; 36(10):701-6. PubMed ID: 15483751
[TBL] [Abstract][Full Text] [Related]
16. Immune responses of recombinant adenovirus co-expressing VP1 of foot-and-mouth disease virus and porcine interferon alpha in mice and guinea pigs.
Du Y; Dai J; Li Y; Li C; Qi J; Duan S; Jiang P
Vet Immunol Immunopathol; 2008 Aug; 124(3-4):274-83. PubMed ID: 18511133
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity and protective efficacy of a novel foot-and-mouth disease virus empty-capsid-like particle with improved acid stability.
Xie Y; Li H; Qi X; Ma Y; Yang B; Zhang S; Chang H; Yin X; Li Z
Vaccine; 2019 Mar; 37(14):2016-2025. PubMed ID: 30808570
[TBL] [Abstract][Full Text] [Related]
18. Large-scale production of foot-and-mouth disease virus (serotype Asia1) VLP vaccine in Escherichia coli and protection potency evaluation in cattle.
Xiao Y; Chen HY; Wang Y; Yin B; Lv C; Mo X; Yan H; Xuan Y; Huang Y; Pang W; Li X; Yuan YA; Tian K
BMC Biotechnol; 2016 Jul; 16(1):56. PubMed ID: 27371162
[TBL] [Abstract][Full Text] [Related]
19. Artificially designed hepatitis B virus core particles composed of multiple epitopes of type A and O foot-and-mouth disease virus as a bivalent vaccine candidate.
Lei Y; Shao J; Zhao F; Li Y; Lei C; Ma F; Chang H; Zhang Y
J Med Virol; 2019 Dec; 91(12):2142-2152. PubMed ID: 31347713
[TBL] [Abstract][Full Text] [Related]
20. FMD empty capsids combined with the Immunostant Particle Adjuvant -ISPA or ISA206 induce protective immunity against foot and mouth disease virus.
Bidart J; Mignaqui A; Kornuta C; Lupi G; Gammella M; Soria I; Galarza R; Ferella A; Cardillo S; Langellotti C; Quattrocchi V; Durocher Y; Wigdorovitz A; Marcipar I; Zamorano P
Virus Res; 2021 May; 297():198339. PubMed ID: 33596405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
